D3S-001

CAT:
931-T89626-01
Size:
10 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
D3S-001 - image 1

D3S-001

  • Target :

    Ras|||Kras
  • Related Pathways :

    MAPK
  • Bioactivity :

    D3S-001 is an orally effective KRAS inhibitor. It suppresses the proliferation of the KRASG12C mutants H358 and MIA-PA-CA-2 with IC50 values of 0.6 and 0.44 nM, respectively. D3S-001 exhibits good metabolic stability across multiple species in hepatocytes, liver microsomes, plasma, and whole blood. Additionally, it demonstrates favorable pharmacokinetic properties and antitumor activity in mice.
  • Smiles :

    C(OC1=NC(=C2C(=N1)C[C@H](OC2)C3=C(C(F)(F)F)C(C)=CC(N)=C3F)N4C[C@H](CC#N)N(C(C(=C)F)=O)CC4)[C@@]56N(C[C@H](F)C5)CCC6
  • Molecular Formula :

    C32H35F6N7O3
  • Molecular Weight :

    679.66
  • Shipping Conditions :

    Cool pack
  • Storage Temperature :

    -20°C
  • CAS Number :

    2914919-85-8

Featured Selection

Popular Products

Discover our most sought-after biotechnology products, trusted by researchers worldwide